Article

Gut microbiome is associated with recurrence-free survival in patients with resected Stage IIIB-D or Stage IV melanoma treated with immune checkpoint inhibitors

2024-04-20

Abstract excerpt

<h4>Summary</h4> The gut microbiome (GMB) has been associated with outcomes of immune checkpoint blockade therapy in melanoma, but there is limited consensus on the specific taxa involved, particularly across different geographic regions. We analyzed pre-treatment stool samples from 674 melanoma patients participating in a phase-III trial of adjuvant nivolumab plus ipilimumab versus nivolumab, across three contin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3c98b1e7-2b0e-563d-ad53-d9573f7cab68
DOI: 10.1101/2024.04.16.589761

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Gut microbiome is associated with recurrence-free survival in patients with resected Stage IIIB-D or Stage IV melanoma treated with immune checkpoint inhibitorsDOI 10.1101/2024.04.16.589761Read

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanomaSemantic proximity Read

Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanomaSemantic proximity Read

Taxonomy-free fecal microbiome profiles enable robust prediction of immunotherapy response and toxicity in melanomaSemantic proximity Read

Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patientsSemantic proximity Read

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeSemantic proximity Read

A gut microbial signature for combination immune checkpoint blockade across cancer typesSemantic proximity Read

The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitorsSemantic proximity Read

A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint InhibitorsSemantic proximity Read

Gut Microbiota Shifts from Onset to Remission in Immune Checkpoint Inhibitor-Induced Enterocolitis: A Case ReportSemantic proximity Read

Meta-analytic microbiome target discovery for immune checkpoint inhibitor response in advanced melanomaSemantic proximity Read

Microbiome influencers of checkpoint blockade–associated toxicitySemantic proximity Read

Melanoma and microbiota: Current understanding and future directionsSemantic proximity Read